CD38 Monoclonal Antibody Drugs Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of CD38 Monoclonal Antibody Drugs in global, including the following market information:
Global CD38 Monoclonal Antibody Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global CD38 Monoclonal Antibody Drugs Market Sales, 2017-2022, 2023-2028, (KG)
Global top five CD38 Monoclonal Antibody Drugs companies in 2021 (%)
The global CD38 Monoclonal Antibody Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Daretuzumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CD38 Monoclonal Antibody Drugs include Johnson, Sanofi, Takeda Pharmaceutical Company, CASI Pharmaceutical Company and Mab Biopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD38 Monoclonal Antibody Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CD38 Monoclonal Antibody Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global CD38 Monoclonal Antibody Drugs Market Segment Percentages, by Type, 2021 (%)
Global CD38 Monoclonal Antibody Drugs Market Segment Percentages, by Application, 2021 (%)
Global CD38 Monoclonal Antibody Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies CD38 Monoclonal Antibody Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies CD38 Monoclonal Antibody Drugs revenues share in global market, 2021 (%)
Key companies CD38 Monoclonal Antibody Drugs sales in global market, 2017-2022 (Estimated), (KG)
Key companies CD38 Monoclonal Antibody Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global CD38 Monoclonal Antibody Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global CD38 Monoclonal Antibody Drugs Market Sales, 2017-2022, 2023-2028, (KG)
Global top five CD38 Monoclonal Antibody Drugs companies in 2021 (%)
The global CD38 Monoclonal Antibody Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Daretuzumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CD38 Monoclonal Antibody Drugs include Johnson, Sanofi, Takeda Pharmaceutical Company, CASI Pharmaceutical Company and Mab Biopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD38 Monoclonal Antibody Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CD38 Monoclonal Antibody Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global CD38 Monoclonal Antibody Drugs Market Segment Percentages, by Type, 2021 (%)
- Daretuzumab
- Isartuximab
- Engineered Toxin Body
Global CD38 Monoclonal Antibody Drugs Market Segment Percentages, by Application, 2021 (%)
- Multiple Myeloma
- Diffuse Large B Cell Lymphoma
- Other
Global CD38 Monoclonal Antibody Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies CD38 Monoclonal Antibody Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies CD38 Monoclonal Antibody Drugs revenues share in global market, 2021 (%)
Key companies CD38 Monoclonal Antibody Drugs sales in global market, 2017-2022 (Estimated), (KG)
Key companies CD38 Monoclonal Antibody Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson
- Sanofi
- Takeda Pharmaceutical Company
- CASI Pharmaceutical Company
- Mab Biopharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 CD38 Monoclonal Antibody Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD38 Monoclonal Antibody Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CD38 MONOCLONAL ANTIBODY DRUGS OVERALL MARKET SIZE
2.1 Global CD38 Monoclonal Antibody Drugs Market Size: 2021 VS 2028
2.2 Global CD38 Monoclonal Antibody Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global CD38 Monoclonal Antibody Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top CD38 Monoclonal Antibody Drugs Players in Global Market
3.2 Top Global CD38 Monoclonal Antibody Drugs Companies Ranked by Revenue
3.3 Global CD38 Monoclonal Antibody Drugs Revenue by Companies
3.4 Global CD38 Monoclonal Antibody Drugs Sales by Companies
3.5 Global CD38 Monoclonal Antibody Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 CD38 Monoclonal Antibody Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers CD38 Monoclonal Antibody Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 CD38 Monoclonal Antibody Drugs Players in Global Market
3.8.1 List of Global Tier 1 CD38 Monoclonal Antibody Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 CD38 Monoclonal Antibody Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global CD38 Monoclonal Antibody Drugs Market Size Markets, 2021 & 2028
4.1.2 Daretuzumab
4.1.3 Isartuximab
4.1.4 Engineered Toxin Body
4.2 By Type - Global CD38 Monoclonal Antibody Drugs Revenue & Forecasts
4.2.1 By Type - Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2022
4.2.2 By Type - Global CD38 Monoclonal Antibody Drugs Revenue, 2023-2028
4.2.3 By Type - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global CD38 Monoclonal Antibody Drugs Sales & Forecasts
4.3.1 By Type - Global CD38 Monoclonal Antibody Drugs Sales, 2017-2022
4.3.2 By Type - Global CD38 Monoclonal Antibody Drugs Sales, 2023-2028
4.3.3 By Type - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
4.4 By Type - Global CD38 Monoclonal Antibody Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global CD38 Monoclonal Antibody Drugs Market Size, 2021 & 2028
5.1.2 Multiple Myeloma
5.1.3 Diffuse Large B Cell Lymphoma
5.1.4 Other
5.2 By Application - Global CD38 Monoclonal Antibody Drugs Revenue & Forecasts
5.2.1 By Application - Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2022
5.2.2 By Application - Global CD38 Monoclonal Antibody Drugs Revenue, 2023-2028
5.2.3 By Application - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global CD38 Monoclonal Antibody Drugs Sales & Forecasts
5.3.1 By Application - Global CD38 Monoclonal Antibody Drugs Sales, 2017-2022
5.3.2 By Application - Global CD38 Monoclonal Antibody Drugs Sales, 2023-2028
5.3.3 By Application - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
5.4 By Application - Global CD38 Monoclonal Antibody Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global CD38 Monoclonal Antibody Drugs Market Size, 2021 & 2028
6.2 By Region - Global CD38 Monoclonal Antibody Drugs Revenue & Forecasts
6.2.1 By Region - Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2022
6.2.2 By Region - Global CD38 Monoclonal Antibody Drugs Revenue, 2023-2028
6.2.3 By Region - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global CD38 Monoclonal Antibody Drugs Sales & Forecasts
6.3.1 By Region - Global CD38 Monoclonal Antibody Drugs Sales, 2017-2022
6.3.2 By Region - Global CD38 Monoclonal Antibody Drugs Sales, 2023-2028
6.3.3 By Region - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.4.2 By Country - North America CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.4.3 US CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.4.4 Canada CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.4.5 Mexico CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.5.2 By Country - Europe CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.5.3 Germany CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.4 France CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.5 U.K. CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.6 Italy CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.7 Russia CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.8 Nordic Countries CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.9 Benelux CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.6.2 By Region - Asia CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.6.3 China CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.4 Japan CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.5 South Korea CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.6 Southeast Asia CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.7 India CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.7.2 By Country - South America CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.7.3 Brazil CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.7.4 Argentina CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.8.3 Turkey CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8.4 Israel CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8.6 UAE CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson
7.1.1 Johnson Corporate Summary
7.1.2 Johnson Business Overview
7.1.3 Johnson CD38 Monoclonal Antibody Drugs Major Product Offerings
7.1.4 Johnson CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi CD38 Monoclonal Antibody Drugs Major Product Offerings
7.2.4 Sanofi CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Takeda Pharmaceutical Company
7.3.1 Takeda Pharmaceutical Company Corporate Summary
7.3.2 Takeda Pharmaceutical Company Business Overview
7.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Major Product Offerings
7.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Takeda Pharmaceutical Company Key News
7.4 CASI Pharmaceutical Company
7.4.1 CASI Pharmaceutical Company Corporate Summary
7.4.2 CASI Pharmaceutical Company Business Overview
7.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Major Product Offerings
7.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.4.5 CASI Pharmaceutical Company Key News
7.5 Mab Biopharma
7.5.1 Mab Biopharma Corporate Summary
7.5.2 Mab Biopharma Business Overview
7.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Major Product Offerings
7.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Mab Biopharma Key News
8 GLOBAL CD38 MONOCLONAL ANTIBODY DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global CD38 Monoclonal Antibody Drugs Production Capacity, 2017-2028
8.2 CD38 Monoclonal Antibody Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global CD38 Monoclonal Antibody Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CD38 MONOCLONAL ANTIBODY DRUGS SUPPLY CHAIN ANALYSIS
10.1 CD38 Monoclonal Antibody Drugs Industry Value Chain
10.2 CD38 Monoclonal Antibody Drugs Upstream Market
10.3 CD38 Monoclonal Antibody Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 CD38 Monoclonal Antibody Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 CD38 Monoclonal Antibody Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD38 Monoclonal Antibody Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CD38 MONOCLONAL ANTIBODY DRUGS OVERALL MARKET SIZE
2.1 Global CD38 Monoclonal Antibody Drugs Market Size: 2021 VS 2028
2.2 Global CD38 Monoclonal Antibody Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global CD38 Monoclonal Antibody Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top CD38 Monoclonal Antibody Drugs Players in Global Market
3.2 Top Global CD38 Monoclonal Antibody Drugs Companies Ranked by Revenue
3.3 Global CD38 Monoclonal Antibody Drugs Revenue by Companies
3.4 Global CD38 Monoclonal Antibody Drugs Sales by Companies
3.5 Global CD38 Monoclonal Antibody Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 CD38 Monoclonal Antibody Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers CD38 Monoclonal Antibody Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 CD38 Monoclonal Antibody Drugs Players in Global Market
3.8.1 List of Global Tier 1 CD38 Monoclonal Antibody Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 CD38 Monoclonal Antibody Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global CD38 Monoclonal Antibody Drugs Market Size Markets, 2021 & 2028
4.1.2 Daretuzumab
4.1.3 Isartuximab
4.1.4 Engineered Toxin Body
4.2 By Type - Global CD38 Monoclonal Antibody Drugs Revenue & Forecasts
4.2.1 By Type - Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2022
4.2.2 By Type - Global CD38 Monoclonal Antibody Drugs Revenue, 2023-2028
4.2.3 By Type - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global CD38 Monoclonal Antibody Drugs Sales & Forecasts
4.3.1 By Type - Global CD38 Monoclonal Antibody Drugs Sales, 2017-2022
4.3.2 By Type - Global CD38 Monoclonal Antibody Drugs Sales, 2023-2028
4.3.3 By Type - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
4.4 By Type - Global CD38 Monoclonal Antibody Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global CD38 Monoclonal Antibody Drugs Market Size, 2021 & 2028
5.1.2 Multiple Myeloma
5.1.3 Diffuse Large B Cell Lymphoma
5.1.4 Other
5.2 By Application - Global CD38 Monoclonal Antibody Drugs Revenue & Forecasts
5.2.1 By Application - Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2022
5.2.2 By Application - Global CD38 Monoclonal Antibody Drugs Revenue, 2023-2028
5.2.3 By Application - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global CD38 Monoclonal Antibody Drugs Sales & Forecasts
5.3.1 By Application - Global CD38 Monoclonal Antibody Drugs Sales, 2017-2022
5.3.2 By Application - Global CD38 Monoclonal Antibody Drugs Sales, 2023-2028
5.3.3 By Application - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
5.4 By Application - Global CD38 Monoclonal Antibody Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global CD38 Monoclonal Antibody Drugs Market Size, 2021 & 2028
6.2 By Region - Global CD38 Monoclonal Antibody Drugs Revenue & Forecasts
6.2.1 By Region - Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2022
6.2.2 By Region - Global CD38 Monoclonal Antibody Drugs Revenue, 2023-2028
6.2.3 By Region - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global CD38 Monoclonal Antibody Drugs Sales & Forecasts
6.3.1 By Region - Global CD38 Monoclonal Antibody Drugs Sales, 2017-2022
6.3.2 By Region - Global CD38 Monoclonal Antibody Drugs Sales, 2023-2028
6.3.3 By Region - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.4.2 By Country - North America CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.4.3 US CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.4.4 Canada CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.4.5 Mexico CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.5.2 By Country - Europe CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.5.3 Germany CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.4 France CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.5 U.K. CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.6 Italy CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.7 Russia CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.8 Nordic Countries CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.5.9 Benelux CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.6.2 By Region - Asia CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.6.3 China CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.4 Japan CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.5 South Korea CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.6 Southeast Asia CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.6.7 India CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.7.2 By Country - South America CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.7.3 Brazil CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.7.4 Argentina CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales, 2017-2028
6.8.3 Turkey CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8.4 Israel CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
6.8.6 UAE CD38 Monoclonal Antibody Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson
7.1.1 Johnson Corporate Summary
7.1.2 Johnson Business Overview
7.1.3 Johnson CD38 Monoclonal Antibody Drugs Major Product Offerings
7.1.4 Johnson CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi CD38 Monoclonal Antibody Drugs Major Product Offerings
7.2.4 Sanofi CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Takeda Pharmaceutical Company
7.3.1 Takeda Pharmaceutical Company Corporate Summary
7.3.2 Takeda Pharmaceutical Company Business Overview
7.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Major Product Offerings
7.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Takeda Pharmaceutical Company Key News
7.4 CASI Pharmaceutical Company
7.4.1 CASI Pharmaceutical Company Corporate Summary
7.4.2 CASI Pharmaceutical Company Business Overview
7.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Major Product Offerings
7.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.4.5 CASI Pharmaceutical Company Key News
7.5 Mab Biopharma
7.5.1 Mab Biopharma Corporate Summary
7.5.2 Mab Biopharma Business Overview
7.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Major Product Offerings
7.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Mab Biopharma Key News
8 GLOBAL CD38 MONOCLONAL ANTIBODY DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global CD38 Monoclonal Antibody Drugs Production Capacity, 2017-2028
8.2 CD38 Monoclonal Antibody Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global CD38 Monoclonal Antibody Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CD38 MONOCLONAL ANTIBODY DRUGS SUPPLY CHAIN ANALYSIS
10.1 CD38 Monoclonal Antibody Drugs Industry Value Chain
10.2 CD38 Monoclonal Antibody Drugs Upstream Market
10.3 CD38 Monoclonal Antibody Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 CD38 Monoclonal Antibody Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of CD38 Monoclonal Antibody Drugs in Global Market
Table 2. Top CD38 Monoclonal Antibody Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global CD38 Monoclonal Antibody Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global CD38 Monoclonal Antibody Drugs Revenue Share by Companies, 2017-2022
Table 5. Global CD38 Monoclonal Antibody Drugs Sales by Companies, (KG), 2017-2022
Table 6. Global CD38 Monoclonal Antibody Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers CD38 Monoclonal Antibody Drugs Price (2017-2022) & (US$/g)
Table 8. Global Manufacturers CD38 Monoclonal Antibody Drugs Product Type
Table 9. List of Global Tier 1 CD38 Monoclonal Antibody Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD38 Monoclonal Antibody Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2017-2022
Table 15. By Type - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2023-2028
Table 16. By Application – Global CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2017-2022
Table 20. By Application - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2023-2028
Table 21. By Region – Global CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2017-2022
Table 25. By Region - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2023-2028
Table 26. By Country - North America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 29. By Country - North America CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 30. By Country - Europe CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 33. By Country - Europe CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 34. By Region - Asia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 37. By Region - Asia CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 38. By Country - South America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 41. By Country - South America CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 46. Johnson Corporate Summary
Table 47. Johnson CD38 Monoclonal Antibody Drugs Product Offerings
Table 48. Johnson CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi CD38 Monoclonal Antibody Drugs Product Offerings
Table 51. Sanofi CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 52. Takeda Pharmaceutical Company Corporate Summary
Table 53. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Offerings
Table 54. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 55. CASI Pharmaceutical Company Corporate Summary
Table 56. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Offerings
Table 57. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 58. Mab Biopharma Corporate Summary
Table 59. Mab Biopharma CD38 Monoclonal Antibody Drugs Product Offerings
Table 60. Mab Biopharma CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 61. CD38 Monoclonal Antibody Drugs Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 62. Global CD38 Monoclonal Antibody Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global CD38 Monoclonal Antibody Drugs Production by Region, 2017-2022 (KG)
Table 64. Global CD38 Monoclonal Antibody Drugs Production by Region, 2023-2028 (KG)
Table 65. CD38 Monoclonal Antibody Drugs Market Opportunities & Trends in Global Market
Table 66. CD38 Monoclonal Antibody Drugs Market Drivers in Global Market
Table 67. CD38 Monoclonal Antibody Drugs Market Restraints in Global Market
Table 68. CD38 Monoclonal Antibody Drugs Raw Materials
Table 69. CD38 Monoclonal Antibody Drugs Raw Materials Suppliers in Global Market
Table 70. Typical CD38 Monoclonal Antibody Drugs Downstream
Table 71. CD38 Monoclonal Antibody Drugs Downstream Clients in Global Market
Table 72. CD38 Monoclonal Antibody Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of CD38 Monoclonal Antibody Drugs in Global Market
Table 2. Top CD38 Monoclonal Antibody Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global CD38 Monoclonal Antibody Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global CD38 Monoclonal Antibody Drugs Revenue Share by Companies, 2017-2022
Table 5. Global CD38 Monoclonal Antibody Drugs Sales by Companies, (KG), 2017-2022
Table 6. Global CD38 Monoclonal Antibody Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers CD38 Monoclonal Antibody Drugs Price (2017-2022) & (US$/g)
Table 8. Global Manufacturers CD38 Monoclonal Antibody Drugs Product Type
Table 9. List of Global Tier 1 CD38 Monoclonal Antibody Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD38 Monoclonal Antibody Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2017-2022
Table 15. By Type - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2023-2028
Table 16. By Application – Global CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2017-2022
Table 20. By Application - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2023-2028
Table 21. By Region – Global CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global CD38 Monoclonal Antibody Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2017-2022
Table 25. By Region - Global CD38 Monoclonal Antibody Drugs Sales (KG), 2023-2028
Table 26. By Country - North America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 29. By Country - North America CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 30. By Country - Europe CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 33. By Country - Europe CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 34. By Region - Asia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 37. By Region - Asia CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 38. By Country - South America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 41. By Country - South America CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales, (KG), 2023-2028
Table 46. Johnson Corporate Summary
Table 47. Johnson CD38 Monoclonal Antibody Drugs Product Offerings
Table 48. Johnson CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi CD38 Monoclonal Antibody Drugs Product Offerings
Table 51. Sanofi CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 52. Takeda Pharmaceutical Company Corporate Summary
Table 53. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Offerings
Table 54. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 55. CASI Pharmaceutical Company Corporate Summary
Table 56. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Offerings
Table 57. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 58. Mab Biopharma Corporate Summary
Table 59. Mab Biopharma CD38 Monoclonal Antibody Drugs Product Offerings
Table 60. Mab Biopharma CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/g) (2017-2022)
Table 61. CD38 Monoclonal Antibody Drugs Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 62. Global CD38 Monoclonal Antibody Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global CD38 Monoclonal Antibody Drugs Production by Region, 2017-2022 (KG)
Table 64. Global CD38 Monoclonal Antibody Drugs Production by Region, 2023-2028 (KG)
Table 65. CD38 Monoclonal Antibody Drugs Market Opportunities & Trends in Global Market
Table 66. CD38 Monoclonal Antibody Drugs Market Drivers in Global Market
Table 67. CD38 Monoclonal Antibody Drugs Market Restraints in Global Market
Table 68. CD38 Monoclonal Antibody Drugs Raw Materials
Table 69. CD38 Monoclonal Antibody Drugs Raw Materials Suppliers in Global Market
Table 70. Typical CD38 Monoclonal Antibody Drugs Downstream
Table 71. CD38 Monoclonal Antibody Drugs Downstream Clients in Global Market
Table 72. CD38 Monoclonal Antibody Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. CD38 Monoclonal Antibody Drugs Segment by Type
Figure 2. CD38 Monoclonal Antibody Drugs Segment by Application
Figure 3. Global CD38 Monoclonal Antibody Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CD38 Monoclonal Antibody Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. CD38 Monoclonal Antibody Drugs Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by CD38 Monoclonal Antibody Drugs Revenue in 2021
Figure 9. By Type - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global CD38 Monoclonal Antibody Drugs Price (US$/g), 2017-2028
Figure 12. By Application - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global CD38 Monoclonal Antibody Drugs Price (US$/g), 2017-2028
Figure 15. By Region - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 19. US CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 24. Germany CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 33. China CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 40. Brazil CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 44. Turkey CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global CD38 Monoclonal Antibody Drugs Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production CD38 Monoclonal Antibody Drugs by Region, 2021 VS 2028
Figure 50. CD38 Monoclonal Antibody Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. CD38 Monoclonal Antibody Drugs Segment by Type
Figure 2. CD38 Monoclonal Antibody Drugs Segment by Application
Figure 3. Global CD38 Monoclonal Antibody Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CD38 Monoclonal Antibody Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CD38 Monoclonal Antibody Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. CD38 Monoclonal Antibody Drugs Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by CD38 Monoclonal Antibody Drugs Revenue in 2021
Figure 9. By Type - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global CD38 Monoclonal Antibody Drugs Price (US$/g), 2017-2028
Figure 12. By Application - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global CD38 Monoclonal Antibody Drugs Price (US$/g), 2017-2028
Figure 15. By Region - Global CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 19. US CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 24. Germany CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 33. China CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 40. Brazil CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa CD38 Monoclonal Antibody Drugs Sales Market Share, 2017-2028
Figure 44. Turkey CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE CD38 Monoclonal Antibody Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global CD38 Monoclonal Antibody Drugs Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production CD38 Monoclonal Antibody Drugs by Region, 2021 VS 2028
Figure 50. CD38 Monoclonal Antibody Drugs Industry Value Chain
Figure 51. Marketing Channels
